HLS Therapeutics Inc.
HLS.TOTSXHealthcare● Active
$4.41
$-0.06(-1.34%)
Market Cap$137917017
P/E Ratio—
52W High$5.765
52W Low$0.001
HLS Therapeutics Inc. (HLS.TO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HLS.TO · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $11.70M | $17.46M | $21.95M | $20.72M | $21.18M |
| Net Receivables | $7.85M | $7.53M | $10.69M | $11.19M | $11.51M |
| Inventory | $8.12M | $9.06M | $9.53M | $8.90M | $8.93M |
| Total Current Assets | $29.04M | $35.40M | $44.09M | $44.37M | $43.75M |
| PP&E Net | $1.34M | $1.00M | $0.96M | $1.13M | $1.57M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $105.43M | $122.12M | $162.34M | $195.02M | $229.18M |
| Total Assets | $137.28M | $159.90M | $209.06M | $241.65M | $275.90M |
| Liabilities | |||||
| Short-Term Debt | $4.81M | $4.83M | $4.69M | $13.06M | $12.00M |
| Accounts Payable | $10.42M | $8.71M | $14.11M | $11.59M | $9.32M |
| Total Current Liabilities | $26.07M | $22.55M | $26.69M | $31.19M | $27.67M |
| Long-Term Debt | $44.37M | $60.74M | $82.05M | $83.28M | $84.13M |
| Total Liabilities | $75.72M | $88.56M | $111.36M | $116.33M | $115.17M |
| Stockholders Equity | |||||
| Retained Earnings | ($203.78M) | ($194.18M) | ($175.46M) | ($148.45M) | ($119.86M) |
| Total Stockholders Equity | $61.56M | $71.34M | $97.70M | $125.32M | $160.74M |
| Total Liab & Equity(computed) | $137.28M | $159.90M | $209.06M | $241.65M | $275.90M |
| Debt Summary | |||||
| Total Debt | $49.73M | $66.45M | $87.62M | $97.34M | $97.57M |
| Net Debt | $38.03M | $48.99M | $65.67M | $76.62M | $76.39M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more HLS Therapeutics Inc. data
About HLS Therapeutics Inc. (HLS.TO) Balance Sheet
HLS Therapeutics Inc. (HLS.TO) balance sheet shows total assets of $0.14B with cash of $0.01B. Total liabilities are $0.08B, total debt $0.05B, and stockholders equity $0.06B.
Frequently asked questions
HLS.TO · 4 questionsHLS Therapeutics Inc. has total debt of $0.05B with net debt of $0.04B.
HLS.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10